Related Experiment Videos
The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspective
R M Califf1, F E Harrell, K L Lee
1Department of Medicine, Duke University Medical Center, Durham, NC 27710.
Insights
Coronary artery bypass surgery significantly improves survival for patients with severe coronary artery disease, especially those with poor medical prognoses. Outcomes improved over time, making surgery superior to medical therapy for most.
Area of Science:
- Cardiology
- Cardiac Surgery
- Public Health
Background:
- Coronary artery disease (CAD) remains a leading cause of mortality worldwide.
- Identifying predictors of improved survival after revascularization is crucial for patient selection and treatment optimization.
- Coronary artery bypass surgery (CABS) is a major intervention for advanced CAD.
Purpose of the Study:
- To identify factors associated with enhanced survival after coronary artery bypass surgery (CABS).
- To compare the long-term efficacy of surgical versus medical therapy for coronary artery disease (CAD).
- To assess the impact of disease severity and patient-specific factors on surgical outcomes.
Main Methods:
- Retrospective analysis of 5809 patients undergoing medical or surgical therapy for CAD.
- Statistical evaluation of factors influencing survival benefit from CABS.
- Comparison of survival rates between surgical and medical treatment groups over time.
Main Results:
- More severe coronary obstruction, poorer medical prognosis, and recent operative dates were linked to significant survival benefits with CABS.
- Patients with extensive CAD experienced the greatest survival improvements.
- Survival rates following CABS improved progressively, surpassing medical therapy by 1984 for most subgroups.
Conclusions:
- Contemporary coronary revascularization, particularly CABS, offers improved longevity for many patients with ischemic heart disease.
- Patients with adverse prognostic indicators, such as severe angina or left ventricular dysfunction, derive substantial benefit from surgical intervention.
- The study highlights the importance of considering disease severity and individual risk factors when choosing between medical and surgical management for CAD.
Abstract:
To elucidate the factors associated with improved survival following coronary artery bypass surgery, we studied 5809 patients receiving medical or surgical therapy for coronary artery disease. Three factors were associated with a significant surgical survival benefit: more severe coronary disease, a worse prognosis with medical therapy, and a more recent operative date. Patients with more extensive coronary obstruction had the greatest improvement in survival. Patients with a poor prognosis because of factors such as older age, severe angina, or left ventricular dysfunction had a reduction in risk that was proportionate to their overall risk on medical therapy. Survival with surgery progressively improved over the study period and by 1984 surgery was significantly better than medical therapy for most patient subgroups. Thus, contemporary coronary revascularization is associated with improved longevity in many patients with ischemic heart disease, especially in those with adverse prognostic indicators.